Latest News

Emergency gout admission increase is ‘call to arms’


 

AT RHEUMATOLOGY 2018

– The rate of emergency hospital admissions for gout in England has seen a 59% increase over the past decade, while that of rheumatoid arthritis has halved, it was reported at the British Society for Rheumatology annual conference.

Over an approximate 10-year period (2006-2017), the incidence rate of unplanned gout admissions increased from 7.9 to 12.5 admissions per 100,000 of the population. This represented an increase from 0.023% to 0.032% of all hospital admissions during the period.

To put that into perspective, unplanned admissions for rheumatoid arthritis (RA), decreased from 8.6 to 4.3 admissions per 100,000 of the population, said Mark D. Russell, MD, a rheumatology registrar at Guy’s and St Thomas’ Hospital in London.

Furthermore, primary care prescriptions for common gout medications have seen a dramatic increase over the same time period in England; allopurinol prescriptions are up 72%, there’s been a 166% increase in colchicine prescriptions, and a 20-fold increase in febuxostat (Uloric) prescriptions since data became available for its in 2010.

“Gout’s very much a treatable condition,” Dr. Russell said, but with 82% of all gout admissions being unplanned, “there’s clearly more to do; this should be a call to arms for rheumatologists to help reduce the in-patient burden of this condition.”

The mean length of hospital stay was estimated at 6.6 days, with the median being 3.2 days. Gout accounted for just under 350,000 hospital bed days from 2006 to 2017, and with the cost of a single gout admission being anything from £850 up to £5,600, it constitutes a significant burden for the country’s National Health Service.

But what can be done? Would a “door-to-needle time campaign” help? So that when patients attend the emergency department they are assessed rapidly and treated accordingly? Dr. Russell queried.

Education could be the key, was the consensus during the discussion following his presentation. Education, and not just of those affected by the condition, but also of the family physicians who seem to have a “knee-jerk reaction” to prescribe medications, and not always appropriately. Even hospital staff may need help in differentiating gout from other emergency presentations, with some admitting patients suspecting infection or wrongly discharging them.

Pages

Recommended Reading

FDA approves once-daily treatment for hyperuricemia in gout
MDedge Rheumatology
Allopurinol extension trial backs treat-to-target approach in gout
MDedge Rheumatology
Febuxostat prevents early gout flares
MDedge Rheumatology
Gout incidence is intertwined with serum urate, but only up to a point
MDedge Rheumatology
FDA: Febuxostat may have increased heart-related death risk
MDedge Rheumatology
Higher water intake linked to less hyperuricemia in gout
MDedge Rheumatology
Rheumatology 911: Inside the rheumatologic emergency
MDedge Rheumatology
Health disparities in rural America: Chronic conditions
MDedge Rheumatology
Febuxostat increases cardiovascular mortality in CARES trial
MDedge Rheumatology
Allopurinol dose not escalated enough to reduce mortality
MDedge Rheumatology

Related Articles